Program & Downloads
Click here to download the entire book (786KB) –
To navigate in the pages, please use the search tool or the bookmarks.
Click here to see the speakers list
CONGRESS 2012
- Introduction : Hepatitis C : A big step towards eradication - Patrick MARCELLIN (France)
-
8:45 – 10:15
Triple therapy today. Phase III results in G1 naïve patients
Chairs :
Massimo COLOMBO (Italy) Michael MANNS (Germany)
-
8:45
Telaprevir
- Ira JACOBSON (USA)
Download
-
9:05
Boceprevir
- Michael MANNS (Germany)
Download
-
9:25
Safety management in clinical practicee
- Christophe HEZODE (France)
Download
- 9:55 Round table - All speakers
- 10:20 - 10:50 Coffee break
-
10:50 – 12:00
Triple therapy today. Phase III results in G1 relapsers and non responders
Chairs :
Geoffrey DUSHEIKO (UK) Eugene SCHIFF (USA)
-
10:50
Telaprevir
- Stefan ZEUZEM (Germany)
Download
-
11:10
Boceprevir
- Bruce BACON (USA)
Download
- 11:30 Round table - All speakers
-
12:00 – 12:30
State of the Art Lecture
Chairman:
Patrick MARCELLIN (France)
-
The EASL HCV Clinical Practice Guidelines
- Antonio CRAXI (Italy)
Download
-
12:30 – 14:30 Interactive luncheons Room 1
French speaking luncheon : Comment optimiser le traitement des patients naifs
Chair: Patrice COUZIGOU (France)
Speakers:
Najet BELHADJ BRIK (Tunisia)
Download
Denis OUZAN (France)
Download
Rachid OULD GOUGAM (Algeria)
Download
Room 7
Future therapies
Chair: Tarik ASSELAH (France)
Speakers:
Massimo LEVRERO (France)
Download
Francesco NEGRO (Switzerland)
Download
Mark SULKOWSKI (USA)
Download
Room 8
Non invasive markers of fibrosis
Chair: Pierre BEDOSSA (France)
Speakers:
Victor DE LEDINGHEN (France)
Download
Ana Carolina CARDOSO (Brazil)
Download
Paul CALES (France)
Download
-
14:30 – 15:30
What’s new in non G1 ?
Chairs :
Jia-Horng KAO (Taiwan) Alfredo ALBERTI (Italy)
-
14:30
Genotype 2
- Alessandra MANGIA (Italy)
Download
-
14:45
Genotype 3
- Graham FOSTER (UK)
Download
-
15:00
Genotype 4
- Gamal ESMAT (Egypt)
Download
- 15:15 Round table - All speakers
- 15:30 - 16:00 Coffee break
-
16:00 – 17:00
Special Populations
Chairs :
Teerha PIRATVISUTH (Thailand) Sam LEE (Canada)
-
16:00
Cirrhotics
- Marc BOURLIERE (France)
Download
-
16:15
Pre and post liver transplantation
- Didier SAMUEL (France)
Download
-
16:30
HCV-HIV coinfection
- Mark SULKOWSKI (USA)
Download
- 16:45 Round table - All speakers
-
17:00
State of the Art Lecture
Chairman:
Patrick MARCELLIN (France)
- Introduction - Patrick MARCELLIN (France)
-
The history of HCV therapy
- Jay HOOFNAGLE (USA)
Download
- 18:00 Ajournement
- 19:30 Congress Dinner
- Introduction - Patrick MARCELLIN (France)
-
8:45-10:15
Controversies Part 1
Chairs :
Jean-Pierre ZARSKI (France) Nezam AFDHAL (USA)
-
8:45
Telaprevir or Boceprevir ?
- Mitchell SHIFFMAN (USA)
Download
-
9:15
Lead in or no lead in ?
Lawrence SERFATY (France)
Download Graham FOSTER (UK)
Download
-
9:45
Response unguided or guided ?
Raj REDDY (USA)
Download Fabien ZOULIM (France)
Download
- 10:15 - 10:45 Coffee break
-
10:45-11:45
Controversies Part 2
Chairs :
Mark THURSZ (UK) Masao OMATA (Japan)
-
10:45
Do IL28B or not do IL28B ?
Stanislas POL (France)
Download Donald JENSEN (USA)
Download
-
11:15
Resistance is important : Yes or No ?
Christoph SARRAZIN (Germany)
Download Philippe HALFON (France)
Download
-
11:45
State of the Art Lecture
Chairman:
Tarik ASSELAH (France)
- Introduction : Is the game over ? - Raymond SCHINAZI (USA)
- New targets for antivirals against HCV - Ralf BARTENSCHLAGER (Germany)
-
12:30 – 14:30 Interactive Luncheons Room 1
French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs
Chair: Christian TREPO (France)
Speakers:
Mustapha BENAZZOUZ (Morocco)
Download
Mihai VOICULESCU (Romania)
Download
Albert TRAN (France)
Download
Room 2
How to optimize treatment of G1 patient ?
Chairs: Antonio CRAXI (Italy) Marina BERENGUER (Spain)
-
14:30 – 15:00
State of the Art Lecture
Chairman:
Tarik ASSELAH (France)
-
How to improve access to therapy
- Michael FRIED (USA)
Download
-
15:00 - 16:15
The future
Chairs :
Jidong JIA (China) Jake LIANG (USA)
-
15:00
Advantages of new generation DAAs
- Tarik ASSELAH (France)
Download
-
15:20
Is Ribavirin still useful ?
- David NELSON (USA)
Download
-
15:40
Are interferons really necessary ?
- Peter FERENCI (Austria)
Download
- 16:45 Round table - All speakers
-
16:15 -16:30
Conclusion and perspectives
-
Patrick MARCELLIN (France)
Download